Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
The Journal of Infectious Diseases
|
October 13, 2016
No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom
Ellen White, Erasmus Smit, Duncan Churchill, et al.
The New Zealand Medical Journal
|
February 16, 2023
A clinical review of mpox for the Aotearoa New Zealand clinician
Teena Mathew, Eamon Duffy, Erasmus Smit, et al.
Idcases
|
August 2, 2021
Lack of N2-gene amplification on the Cepheid Xpert Xpress SARS-CoV-2 assay and potential novel causative mutations: A case series from Auckland, New Zealand
Shivani Fox-Lewis, Andrew Fox-Lewis, Jay Harrower, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 28, 2016
Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013-2015
Sowsan F Atabani, Steven Wilson, Clare Overton-Lewis, et al.
Sexually Transmitted Infections
|
August 4, 2018
Dried blood spot and mini-tube blood sample collection kits for postal HIV testing services: a comparative review of successes in a real-world setting
Matthew Page, Sowsan F Atabani, Martyn Wood, et al.
The Journal of Antimicrobial Chemotherapy
|
December 16, 2011
Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies
Stephen Taylor, Ashini Jayasuriya, Martin Fisher, et al.
Transplantation
|
June 29, 2018
Toward Systematic Screening for Persistent Hepatitis E Virus Infections in Transplant Patients
Michael J Ankcorn, Samreen Ijaz, John Poh, et al.
The Journal of Antimicrobial Chemotherapy
|
July 16, 2004
Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen
Adil Isaac, Stephen Taylor, Patricia Cane, et al.
The New Zealand Medical Journal
|
August 24, 2022
A comparison of the performance of saliva and nasopharyngeal nucleic acid amplification testing for the detection of SARS-CoV-2 in New Zealand
Gary McAuliffe, Tim Blackmore, Juliet Elvy, et al.
The Journal of Antimicrobial Chemotherapy
|
April 6, 2017
An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs
Erasmus Smit, Ellen White, Duncan Clark, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
The Journal of Infectious Diseases
|
October 13, 2016
No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom
Ellen White, Erasmus Smit, Duncan Churchill, et al.
The New Zealand Medical Journal
|
February 16, 2023
A clinical review of mpox for the Aotearoa New Zealand clinician
Teena Mathew, Eamon Duffy, Erasmus Smit, et al.
Idcases
|
August 2, 2021
Lack of N2-gene amplification on the Cepheid Xpert Xpress SARS-CoV-2 assay and potential novel causative mutations: A case series from Auckland, New Zealand
Shivani Fox-Lewis, Andrew Fox-Lewis, Jay Harrower, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 28, 2016
Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013-2015
Sowsan F Atabani, Steven Wilson, Clare Overton-Lewis, et al.
Sexually Transmitted Infections
|
August 4, 2018
Dried blood spot and mini-tube blood sample collection kits for postal HIV testing services: a comparative review of successes in a real-world setting
Matthew Page, Sowsan F Atabani, Martyn Wood, et al.
The Journal of Antimicrobial Chemotherapy
|
December 16, 2011
Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies
Stephen Taylor, Ashini Jayasuriya, Martin Fisher, et al.
Transplantation
|
June 29, 2018
Toward Systematic Screening for Persistent Hepatitis E Virus Infections in Transplant Patients
Michael J Ankcorn, Samreen Ijaz, John Poh, et al.
The Journal of Antimicrobial Chemotherapy
|
July 16, 2004
Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen
Adil Isaac, Stephen Taylor, Patricia Cane, et al.
The New Zealand Medical Journal
|
August 24, 2022
A comparison of the performance of saliva and nasopharyngeal nucleic acid amplification testing for the detection of SARS-CoV-2 in New Zealand
Gary McAuliffe, Tim Blackmore, Juliet Elvy, et al.
The Journal of Antimicrobial Chemotherapy
|
April 6, 2017
An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs
Erasmus Smit, Ellen White, Duncan Clark, et al.
Page
of 5